Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Molecular Therapy. Methods & Clinical Development
|
April 25, 2018
The Pharmacology of Gene and Cell Therapy
Thomas J Conlon, Fulvio Mavilio
Expert Opinion on Biological Therapy
|
July 23, 2004
Recombinant adeno-associated virus vectors for gene therapy
Thomas J Conlon, Terence R Flotte
Methods in Molecular Biology (Clifton, N.J.)
|
October 29, 2011
Preclinical study design for rAAV
Terence R Flotte, Thomas J Conlon, Christian Mueller
Human Gene Therapy
|
March 23, 2007
Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites
Terence R Flotte, Thomas J Conlon, Amy Poirier, et al.
American Journal of Veterinary Research
|
March 31, 2016
In vitro evaluation of mitochondrial dysfunction and treatment with adeno-associated virus vector in fibroblasts from Doberman Pinschers with dilated cardiomyopathy and a pyruvate dehydrogenase kinase 4 mutation
Ivan Sosa, Amara H Estrada, Brandy D Winter, et al.
The Journal of Gene Medicine
|
May 2, 2007
In vivo expression of human ATP:cob(I)alamin adenosyltransferase (ATR) using recombinant adeno-associated virus (rAAV) serotypes 2 and 8
Kirsten E Erger, Thomas J Conlon, Nicole A Leal, et al.
Genetic Vaccines and Therapy
|
December 12, 2007
Rapid, widespread transduction of the murine myocardium using self-complementary Adeno-associated virus
Lourdes M Andino, Thomas J Conlon, Stacy L Porvasnik, et al.
Human Gene Therapy. Clinical Development
|
July 21, 2017
A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System
William B Guggino, Janet Benson, JeanClare Seagrave, et al.
Human Gene Therapy
|
July 1, 2008
Apparently nonspecific enzyme elevations after portal vein delivery of recombinant adeno-associated virus serotype 2 vector in hepatitis C virus-infected chimpanzees
Terence R Flotte, Jason Goetzmann, James Caridi, et al.
Scientific Reports
|
March 5, 2020
Functional Consequences of PDK4 Deficiency in Doberman Pinscher Fibroblasts
Luiz Bolfer, Amara H Estrada, Chelsea Larkin, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Molecular Therapy. Methods & Clinical Development
|
April 25, 2018
The Pharmacology of Gene and Cell Therapy
Thomas J Conlon, Fulvio Mavilio
Expert Opinion on Biological Therapy
|
July 23, 2004
Recombinant adeno-associated virus vectors for gene therapy
Thomas J Conlon, Terence R Flotte
Methods in Molecular Biology (Clifton, N.J.)
|
October 29, 2011
Preclinical study design for rAAV
Terence R Flotte, Thomas J Conlon, Christian Mueller
Human Gene Therapy
|
March 23, 2007
Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites
Terence R Flotte, Thomas J Conlon, Amy Poirier, et al.
American Journal of Veterinary Research
|
March 31, 2016
In vitro evaluation of mitochondrial dysfunction and treatment with adeno-associated virus vector in fibroblasts from Doberman Pinschers with dilated cardiomyopathy and a pyruvate dehydrogenase kinase 4 mutation
Ivan Sosa, Amara H Estrada, Brandy D Winter, et al.
The Journal of Gene Medicine
|
May 2, 2007
In vivo expression of human ATP:cob(I)alamin adenosyltransferase (ATR) using recombinant adeno-associated virus (rAAV) serotypes 2 and 8
Kirsten E Erger, Thomas J Conlon, Nicole A Leal, et al.
Genetic Vaccines and Therapy
|
December 12, 2007
Rapid, widespread transduction of the murine myocardium using self-complementary Adeno-associated virus
Lourdes M Andino, Thomas J Conlon, Stacy L Porvasnik, et al.
Human Gene Therapy. Clinical Development
|
July 21, 2017
A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System
William B Guggino, Janet Benson, JeanClare Seagrave, et al.
Human Gene Therapy
|
July 1, 2008
Apparently nonspecific enzyme elevations after portal vein delivery of recombinant adeno-associated virus serotype 2 vector in hepatitis C virus-infected chimpanzees
Terence R Flotte, Jason Goetzmann, James Caridi, et al.
Scientific Reports
|
March 5, 2020
Functional Consequences of PDK4 Deficiency in Doberman Pinscher Fibroblasts
Luiz Bolfer, Amara H Estrada, Chelsea Larkin, et al.
Page
of 5